Highlands Oncology Group PA

Highlands Oncology Group PA was paid $5.73M by Medicaid between Jan 2018 and Nov 2024, across 47 billing codes. Its largest line is 96413, Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance — 36% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	29,844	$427K
2019	46,579	$917K
2020	37,399	$969K
2021	41,833	$1.19M
2022	33,454	$1.01M
2023	33,037	$801K
2024incomplete	25,696	$420K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	36%	6,521	5,489	$2.05M
96367		13%	4,328	3,574	$740K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	12%	16,661	13,938	$689K
78815	Positron emission tomography (PET) for limited area imaging	6.1%	536	464	$349K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	5.5%	5,325	4,442	$312K
80053	Comprehensive metabolic panel	3.9%	27,396	18,682	$222K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.8%	31,381	20,384	$161K
71260	Computed tomography, thorax, diagnostic; with contrast material	2.3%	993	897	$133K
83735		2.1%	23,516	15,913	$121K
83615		1.9%	23,329	15,830	$108K
82977		1.9%	15,898	10,325	$106K
82248		1.6%	23,175	15,743	$89K

35 more codes

84100		1.5%	23,381	$85K
84550		1.4%	23,464	$81K
77386		1.3%	203	$77K
77014		1.1%	536	$61K
74178		1.0%	534	$58K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	319	$46K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	672	$31K
99213	Doctor's office visit, returning patient (routine)	<1%	1,187	$28K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	1,405	$25K
96375	Therapeutic injection; each additional sequential IV push	<1%	134	$23K
82728		<1%	2,191	$19K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	115	$15K
82607		<1%	1,492	$14K
83550		<1%	2,209	$12K
82746		<1%	1,309	$12K
77427		<1%	91	$10K
77336		<1%	161	$10K
83540		<1%	2,200	$9K
99232	Hospital visit by a doctor, follow-up day	<1%	243	$7K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	13	$4K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	31	$4K
77334		<1%	27	$3K
70491		<1%	13	$2K
36415	Collection of venous blood by venipuncture	<1%	4,759	$2K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	13	$2K
84443	Thyroid stimulating hormone (TSH)	<1%	1,089	$2K
84436		<1%	317	$1K
96417		<1%	12	$1K
82784		<1%	105	$645.84
99204	Doctor's office visit, new patient (more involved)	<1%	14	$609.65
80050	General health panel	<1%	12	$584.04
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	199	$336.27
82533		<1%	13	$152.72
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	75	$3.18
G9678	Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement	0%	245	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialNAGY, TERESA (CREDENTIALING COORDINATOR)